Du, L., Freitas-Cortez, M.A., Zhang, J., Xue, Y., Veettil, R.T., Zhao, Z., and S.J. Morrison. (2025). Periarteriolar niches become inflamed in aging bone marrow, remodeling the stromal microenvironment and depleting lymphoid progenitors. Procedings of the National Acadmey of Sciences of the United States of America 122:e2412317122. (PubMed)
Freitas-Cortez, M.A., Masrorpour, F., Jiang, H., Mahmud, I., Lu, Y., Huang, A., Duong, L.K., Wang, Q., Voss, T.A., Kettlun Leyton, C.S., Wei, B., Chan, W.K., Lin, K., Zhang, J., Tsouko, E., Ganjoo, S., Barsoumian, H.B., Riad, T.S., Hu, Y., Leuschner, C., Puebla-Osorio, N., Wang, J., Hu, J., Davies, M.A., Puduvalli, V.K., Billon, C., Burris, T.P., Lorenzi, P.L., Gan, B., Welsh, J.W. (2025). Cancer cells avoid ferroptosis induced by immune cells via fatty acid binding proteins. Molecular Cancer 24, 40. (PubMed)
Cortez, M.A., Masrorpour, F., Ivan, C., Zhang, J., Younes, A.I., Lu, Y., Estecio, M.R., Barsoumian, H.B., Menon, H., Caetano, M.D.S., Ramapriyan, R., Schoenhals, J.E., Wang, X., Skoulidis, F., Wasley, M.D., Calin, G., Hwu, P., Welsh, J.W. (2020). Bone morphogenic protein 7 promotes resistance to immunotherapy. Nature Communications 11, 4840. (PubMed)
Cortez, M.A., Ivan, C., Valdecanas, D., Wang, X., Peltier, H.J., Ye, Y., Araujo, L., Carbone, D.P., Shilo, K., Giri, D.K., Kelnar, K., Martin, D., Komaki, R., Gomez, D.R., Krishnan, S., Calin, G.A., Bader, A.G., Welsh, J.W. (2015). PDL1 Regulation by p53 via miR-34. Journal of the National Cancer Institute 108, 303. (PubMed)
Skoulidis, F., Byers, L.A., Diao, L., Papadimitrakopoulou, V.A., Tong, P., Izzo, J., Behrens, C., Kadara, H., Parra, E.R., Canales, J.R., Zhang, J., Giri, U., Gudikote, J., Cortez, M.A., Yang, C., Fan, Y., Peyton, M., Girard, L., Coombes, K.R., Toniatti, C., Heffernan, T.P., Choi, M., Frampton, G.M., Miller, V., Weinstein, J.N., Herbst, R.S., Wong, K.K., Zhang, J., Sharma, P., Mills, G.B., Hong, W.K., Minna, J.D., Allison, J.P., Futreal, A., Wang, J., Wistuba II, Heymach, J.V. (2015). Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities. Cancer Discovery 5, 860-77. (PubMed)
Chen, L., Gibbons, D.L., Goswami, S., Cortez, M.A., Ahn, Y.H., Byers, L.A., Zhang, X., Yi, X., Dwyer, D., Lin, W., Diao, L., Wang, J., Roybal, J., Patel, M., Ungewiss, C., Peng, D., Antonia, S., Mediavilla-Varela, M., Robertson, G., Suraokar, M., Welsh, J.W., Erez, B., Wistuba II, Chen, L., Peng, D., Wang, S., Ullrich, S.E., Heymach, J.V., Kurie, J.M., Qin, F.X. (2014). Metastasis is regulated via microRNA-200/ZEB1 axis control of turmour cell PD-L1 expression and intratumoral immunosuppression. Nature Communications 5, 5241. (PubMed)
Cortez, M.A., Bueso-Ramos, C., Ferdin, J., Lopez-Berestein, G., Sood, A.K., Calin, G.A. (2011). MicroRNAs in body fluids—the mix of hormones and biomarkers. Nature Reviews Clinical Oncology 8, 467-77. (PubMed)
